Drinks with sucrose compared to glucose may cause young adults to produce lower levels of appetite-regulating hormones, according to a new study published in The Journal of Clinical Endocrinology & Metabolism. Too much sugar consumption is a contributing factor for obesity. Sucrose, or “table sugar,” is composed of equal parts glucose and fructose and is often added to...
More than half of adults with type 2 diabetes had long-term remission following gastric bypass surgery, according to a new study published in The Journal of Clinical Endocrinology & Metabolism. Bariatric surgery helps people with severe obesity lose a lot of weight and improve their health. Two common types of bariatric surgery are lap band surgery,...
A drug combo of dapagliflozin and exenatide continues to stay effective at controlling the progression of type 2 diabetes, without loss of effect, after two years of continual use, according to a study recently published in Diabetes Care. In a multi-center double-blind, phase 3, randomized controlled trial, a total of 695 adults whose type 2...
The Endocrine Society has been leading the charge for adopting innovative diabetes care models since 2018. However, the specter of the COVID-19 pandemic has forced the entire healthcare industry to rethink how patients are treated, resulting in an unprecedented wave of innovation that could revolutionize how care is delivered. In early March, Robert A. Gabbay,...
Among the environmental disruptors that contribute to the development of diabetes, air pollution is gaining the spotlight. Airborne microscopic endocrine disruptors not only get in the lungs, but also find their way into the bloodstream where they can cause organ damage, specifically to the pancreas. Health professionals uniformly endorse wearing a mask to lower...
On the cusp of the 100-year anniversary of the discovery of insulin, Endocrine Reviews takes a look at how this therapy has evolved throughout the last century as well as how it has informed treatment options with a comprehensive guide that will prove to be an invaluable resource for another hundred years. Endocrinologists worldwide...
The COVID-19 pandemic has jumpstarted innovation in healthcare delivery and allowed for real-world testing of diabetes care models in unprecedented ways, according to a manuscript published in The Journal of Clinical Endocrinology & Metabolism. For diabetes, which affects half a billion people worldwide, innovation has long been overdue. Currently, less than 50% of people with...
First study to utilize CGM data with FDA-cleared, cloud-based titration software suggests significantly improved outcomes for patients while optimizing clinical resources This past summer, Glytec published the first proof-of-concept study that combines FDA-cleared remote insulin titration software and data from continuous glucose monitoring (CGM) systems. Results of the study, presented at the American Diabetes Association’s...
The Endocrine Society has been leading the charge for adopting innovative diabetes care models since 2018. However, the specter of the COVID-19 pandemic has forced the entire healthcare industry to rethink how patients are treated, resulting in an unprecedented wave of innovation that could revolutionize how care is delivered. In early March, Robert A. Gabbay,...
On the cusp of the 100-year anniversary of the discovery of insulin, Endocrine Reviews takes a look at how this therapy has evolved throughout the last century as well as how it has informed treatment options with a comprehensive guide that will prove to be an invaluable resource for another hundred years. Endocrinologists worldwide...
